LMAT
LeMaitre Vascular, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow -2.1% ·
net new positions -8.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | -4 | 14.59M | $1.39B | +4 | −8 |
| Q1 2026 | 105 | +6 | 13.61M | $1.47B | +7 | −1 |
| Q4 2025 | 99 | 0 | 13.36M | $1.08B | — | — |
| Q3 2025 | 17 | +1 | 7.95M | $695.46M | +1 | — |
| Q2 2025 | 13 | 0 | 7.07M | $587.26M | — | — |
| Q1 2025 | 10 | -2 | 2.25M | $188.56M | — | −2 |
| Q4 2024 | 12 | -1 | 2.09M | $192.81M | — | −1 |
| Q3 2024 | 12 | +2 | 1.29M | $120.13M | +2 | — |
| Q2 2024 | 10 | — | 1.21M | $99.82M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 843.74K | — | $77.74M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 550.26K | +1.4% | $50.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 550.26K | +1.4% | $50.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 284.78K | +0.6% | $26.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 284.78K | +0.6% | $26.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 163.80K | +0.8% | $15.09M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 96.08K | +96.8% | $8.85M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Marshall Wace ✦ | 39.79K | +1530.6% | $3.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 39.79K | +1530.6% | $3.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 36.47K | +14.2% | $3.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 36.47K | +14.2% | $3.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 26.40K | -33.5% | $2.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 20.43K | -11.4% | $1.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 20.43K | -11.4% | $1.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 20.43K | -11.4% | $1.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 18.57K | -62.7% | $1.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 9.83K | +239.5% | $906,013 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 2.35K | -70.9% | $216,805 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Norges Bank | $9.13M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 337 holders, 21.96M shares, $2.32B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.